Ansuvimab-zykl
Generic Name: ansuvimab-zykl
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. Active ingredients: ANSUVIMAB (400 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. Active ingredients: ANSUVIMAB (400 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection, powder, lyophilized, for solution.
Related Medications
Calc Phos, Ferr Phos, Kali Mur
calc phos, ferr phos, kali mur
Uses Temporarily relieves discomfort due to tonsil issues, including sore throat, swelling, mucus, elevated body temperature, enlarged glands, painful swallowing, and head or neck aches. Temporarily supports immunity.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Mebutamate
mebutamate
Manufactured by MEDPOINTE PHARM HLC. Dosage form: TABLET. Route: ORAL. Active ingredients: MEBUTAMATE (600MG). Application: NDA017374.
Carapichea Ipecacuanha Whole
carapichea ipecacuanha whole
Dosage form: LIQUID. Active ingredients: CARAPICHEA IPECACUANHA WHOLE (1 [hp_X]/L). Category: DRUG FOR FURTHER PROCESSING.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.